Symptoms confer higher-than-expected risk of HL, NHLMay 1, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
Vigorous physical activity may lower risk of NHLMay 1, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Susceptibility to 2nd cancers in WM/LPL survivorsApril 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaNon-Hodgkin Lymphoma
Molecule increases TRAIL expression to fight NHLApril 28, 2015Lymphoma & Plasma Cell DisordersPediatricsNon-Hodgkin Lymphoma
‘Watch and wait’ may be inadvisable for CLLApril 24, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
miR expression may predict long-term prognosis in DLBCLApril 24, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Epigenomic findings may help predict relapse in DLBCLApril 21, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
New mAb can overcome resistance to other mAbsApril 20, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Technique helps determine DLBCL subtypesApril 17, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Combo improves PFS in untreated CLLApril 16, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Inhibitor gets orphan designation for DLBCLApril 8, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Test predicts DLBCL relapse better than CT, team saysApril 2, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
FDA grants drug orphan designation for DLBCLApril 2, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
